thalidomide has been researched along with HTLV-I Infections in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
HTLV-I Infections: Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, N | 1 |
| Nagano, Y | 1 |
| Hasegawa, A | 1 |
| Ishizawa, M | 1 |
| Katagiri, K | 1 |
| Yoneda, T | 1 |
| Masuda, T | 1 |
| Kannagi, M | 1 |
| Luna, T | 1 |
| Santos, SB | 1 |
| Nascimento, M | 1 |
| Porto, MA | 1 |
| Muniz, AL | 1 |
| Carvalho, EM | 1 |
| Jesus, AR | 1 |
2 other studies available for thalidomide and HTLV-I Infections
| Article | Year |
|---|---|
Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated growth suppression in HTLV-1-infected cells.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; HTLV-I Infecti | 2021 |
Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.
Topics: Anti-Inflammatory Agents; Case-Control Studies; Colforsin; Female; HTLV-I Infections; Humans; Immuno | 2011 |